Leidos invests $10 million in AI for disease detection and management
Leidos, a technology services vendor specializing in healthcare, national security, and energy sectors, has announced a $10 million investment to accelerate the use of artificial intelligence in detecting and managing diseases. This initiative is in partnership with the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE).
Advancing Healthcare with AI
The collaboration aims to drive research in AI-driven diagnostics and digital pathology to develop innovative tools for healthcare providers. By focusing on diseases like heart disease and cancer, the goal is to reduce diagnostic turnaround times and improve care management through early detection.
The partnership between Leidos and CPACE will involve joint research projects exploring new imaging methods, advanced scanning technologies, and improved techniques for analyzing medical images with precision.
Future of Healthcare Delivery
By merging academic excellence with technological innovation, the collaboration seeks to redefine healthcare delivery and disease management. The University of Pittsburgh’s leadership in diagnosis and healthcare advancements will be further enhanced through this initiative.
Additionally, the collaboration will offer educational programs for the next generation of healthcare and AI innovators. Students will have the opportunity to engage in hands-on internship opportunities and collaborate directly with experts from Leidos.
Industry Trends in AI
Many organizations are leveraging AI to enhance disease detection and prediction. Leidos is expanding its AI capabilities beyond traditional government customers and exploring unconventional partnerships for groundbreaking AI work.
UPitt has a history of leveraging AI for healthcare, from developing diagnostic support platforms to accelerating medical research through partnerships with industry leaders like NVIDIA.
Impact of AI in Healthcare
AI-powered tools have the potential to impact global healthcare by improving diagnoses, treatment plans, and patient outcomes. Proper validation and regulatory compliance are essential for ensuring the widespread adoption of these tools.
Overall, the collaboration between Leidos and CPACE signifies a significant step towards harnessing the power of AI for disease detection and management, ultimately transforming the future of healthcare delivery.
Andrea Fox is senior editor of Healthcare IT News.
Email: afox@himss.org
Healthcare IT News is a HIMSS Media publication.
